Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,130Revenue $M910Net Margin (%)1.9Altman Z-Score3.3
Enterprise Value $M2,398EPS $0.3Operating Margin %4.5Piotroski F-Score5
P/E(ttm)128Beneish M-Score-2.9Pre-tax Margin (%)3.4Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %3.0Quick Ratio1.9Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %-2.2Current Ratio3.0Lower Leverage y-yN
Price/Free Cash Flow460y-y EBITDA Growth Rate %-0.8ROA % (ttm)1.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)2.0Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M51.5ROIC % (ttm)2.1Gross Margin Increase y-yN

Gurus Latest Trades with HAE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HAEJoel Greenblatt 2015-03-31 Buy $36.92 - $45.38
($41.8)
$ 41.37-1%New holding7,510
HAEJames Barrow 2015-03-31 Reduce$36.92 - $45.38
($41.8)
$ 41.37-1%Reduce 0.12%2,345,971
HAEJoel Greenblatt 2014-12-31 Sold Out -0.01%$34.15 - $38.88
($36.69)
$ 41.3713%Sold Out0
HAEJoel Greenblatt 2014-09-30 Reduce$34.1 - $37.1
($35.69)
$ 41.3716%Reduce 23.47%29,531
HAERobert Olstein 2014-06-30 Sold Out -0.06%$30.36 - $35.62
($33.37)
$ 41.3724%Sold Out0
HAEFirst Eagle Investment 2014-06-30 Sold Out $30.36 - $35.62
($33.37)
$ 41.3724%Sold Out0
HAEKen Fisher 2014-06-30 Add$30.36 - $35.62
($33.37)
$ 41.3724%Add 20.48%177,645
HAEJames Barrow 2014-03-31 Add0.1%$31.84 - $43.37
($38.44)
$ 41.378%Add 217.54%3,042,669
HAERobert Olstein 2014-03-31 Buy 0.06%$31.84 - $43.37
($38.44)
$ 41.378%New holding14,400
HAEJoel Greenblatt 2014-03-31 Buy 0.02%$31.84 - $43.37
($38.44)
$ 41.378%New holding42,809
HAEJames Barrow 2013-12-31 Buy 0.06%$38.87 - $43.83
($41.15)
$ 41.371%New holding958,209
HAEThird Avenue Management 2013-12-31 Sold Out -0.03%$38.87 - $43.83
($41.15)
$ 41.371%Sold Out0
HAEThird Avenue Management 2013-06-30 Reduce-0.01%$37.75 - $42.71
($40.49)
$ 41.372%Reduce 27.59%42,000
HAEThird Avenue Management 2013-03-31 Reduce-0.02%$40.78 - $44.44
($41.8)
$ 41.37-1%Reduce 25.64%58,000
HAEKen Fisher 2013-03-31 Add$40.78 - $44.44
($41.8)
$ 41.37-1%Add 26.97%166,920
HAEMeridian Funds 2012-12-31 Add0.29%$38.92 - $41.38
($40.27)
$ 41.373%Add 100.00%354,600
HAEThird Avenue Management 2012-12-31 Reduce-0.17%$38.92 - $41.38
($40.27)
$ 41.373%Reduce 53.77%78,000
HAEKen Fisher 2012-12-31 Add0.01%$38.92 - $41.38
($40.27)
$ 41.373%Add 104.06%131,465
HAEFirst Eagle Investment 2012-12-31 Add$38.92 - $41.38
($40.27)
$ 41.373%Add 100.00%8,000
HAEThird Avenue Management 2012-09-30 Reduce-0.29%$34.325 - $40.7
($37.26)
$ 41.3711%Reduce 49.31%337,444
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HAE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HAE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LINDOP CHRISTOPHER JCFO & EVP Business Development 2015-05-20Sell4,902$41.65-0.67view
HANLON SUSAN MVP Finance 2015-05-05Sell4,000$40.083.22view
CONCANNON BRIANPresident & CEO 2015-05-01Sell4,765$40.741.55view
LINDOP CHRISTOPHER JCFO & EVP Business Development 2015-04-20Sell4,902$41.55-0.43view
CONCANNON BRIANPresident & CEO 2015-04-01Sell4,765$44.51-7.05view
HANLON SUSAN MVP Finance 2015-03-27Sell7,000$43.46-4.81view
LINDOP CHRISTOPHER JCFO & EVP Business Development 2015-03-20Sell4,902$44.26-6.53view
FOOTE SUSAN BARTLETTDirector 2015-03-10Sell11,328$43.84-5.63view
GELBMAN RONALD GDirector 2015-03-05Sell7,707$44.76-7.57view
MERRIMAN RONALDDirector 2015-03-04Sell14,258$43.8-5.55view

Press Releases about HAE :

    Quarterly/Annual Reports about HAE:

    News about HAE:

    Articles On GuruFocus.com
    DENTSPLY´s Growth Opportunities Dec 16 2014 
    Meridian Contrarian Fund Second Quarter Commentary Sep 08 2014 
    Guru Held Stocks Near Historical Low P/B Jul 22 2014 
    The Olstein All Cap Value Fund’s 2014 First Quarter Letter to Shareholders Jul 22 2014 
    This Blood Management Company Can Be A Safe Investment Jul 13 2014 
    Meridian Funds Comments on Haemonetics Aug 28 2013 
    Meridian Funds' Second Quarter 2013 Commentary Aug 28 2013 
    Weeky CFO Sells Highlight: ADBE, HAE, WAGE, OVTI, ICPT Jun 24 2013 
    Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 
    Weekly Guru Bargains Highlights: HAE, DLTR, QCOR, MTX, AMD Jan 21 2013 

    More From Other Websites
    Haemonetics to Present at The East Coast IDEAS Investor Conference May 26 2015
    Haemonetics to Present at The East Coast IDEAS Investor Conference May 26 2015
    Q1 2015: Sales of EUR 45.16 million, net profit EUR 1.23 million May 26 2015
    10-K for Haemonetics Corp. May 24 2015
    HAEMONETICS CORP Files SEC form 10-K, Annual Report May 22 2015
    Haemonetics to Present at The Jefferies 2015 Global Healthcare Conference May 20 2015
    Haemonetics to Present at The Jefferies 2015 Global Healthcare Conference May 20 2015
    Next Week May 15 2015
    An Ideal Healthcare ETF for the Times May 08 2015
    Company News for April 28, 2015 - Corporate Summary Apr 28 2015
    Haemonetics Lags Q4 Earnings, Revenues; FY16 View Bright - Analyst Blog Apr 28 2015
    Haemonetics downgraded by Barrington Research Apr 28 2015
    Haemonetics Corp Earnings Call scheduled for 8:00 am ET today Apr 27 2015
    Haemonetics Expands Executive Management Roles To Complement Global Growth Strategy Apr 27 2015
    Haemonetics Expands Executive Management Roles To Complement Global Growth Strategy Apr 27 2015
    Q4 2015 Haemonetics Corp Earnings Release - Before Market Open Apr 27 2015
    Haemonetics reports 4Q loss Apr 27 2015
    Haemonetics reports 4Q loss Apr 27 2015
    HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 27 2015
    Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full... Apr 27 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK